LexaGene Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. LexaGene Holdings's past years’ income statements indicate that its last revenue has increased compared to the previous period by 29% to $95,476. Profit margin reached -14551%. Total operating expenses were $13,299,110.

Profit Margin

LexaGene Holdings Inc. (LSE:0V43.L): Profit margin
2015 0 -78.97K
2016 0 -80.37K
2018 0 -5.13M
2019 0 -10.95M
2021 73.98K -13.03M -17623.23%
2022 95.47K -13.89M -14550.71%

0V43.L Income Statement (2014 – 2021)

2021 2020 2018 2017 2015 2014
Revenue
Revenue
95.47K73.98K0000
Cost of revenue
688.80K203.61K0000
Gross profit
-593.32K-129.63K0000
Operating exp.
Research and development
7.63M7.54M7.08M3.19M00
Selling and marketing
2.80M2.49M1.66M1.14M00
Total operating expenses
13.29M12.90M10.95M5.13M80.37K78.97K
Operating income
-13.89M-13.03M-10.95M-5.10M-80.29K-78.97K
Other income (expenses), net
-9151031.46K-35.38K-820
Income before tax
-13.89M-13.03M-10.95M-5.13M-80.37K-78.97K
Income tax expense
000000
Net income
-13.89M-13.03M-10.95M-5.13M-80.37K-78.97K
Earnings per share
Basic EPS
-0.12-0.13-0.17-0.09-0.010
Diluted EPS
-0.12-0.13-0.17-0.09-0.010
Data sourceData sourceData sourceData sourceData sourceData source